Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities
about
Identification and regulation of c-Myb target genes in MCF-7 cellsc-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein RELDramatic repositioning of c-Myb to different promoters during the cell cycle observed by combining cell sorting with chromatin immunoprecipitation.p89c-Myb is not required for fetal or adult hematopoiesisSingle molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomasExpression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cellsOptimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptomeMyb proteins: angels and demons in normal and transformed cells.Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cellsMetnase mediates chromosome decatenation in acute leukemia cells.Alternative splicing modulates stem cell differentiation.Adenoid cystic carcinoma: emerging role of translocations and gene fusionsSituational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.Deregulation of splicing factors and breast cancer development.miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.Reassessing the Potential of Myb-targeted Anti-cancer Therapy.Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes.
P2860
Q30996844-FD173621-29D6-4DA2-A7AD-55F24EB44D12Q33604849-202F388A-9B32-476D-A99B-AA0FBE41101CQ33706844-FDDCEC53-1B6A-47BD-A226-036C6C8BF338Q33834014-84B15C0D-2279-4BD3-B745-67E4E6841058Q33846952-3B350E5C-BA3B-4FA3-90C0-95FDE7131A23Q33996833-54FF7044-BE6B-41C3-B7DB-094A19448F24Q34748896-BB2C8F8C-6731-4356-ABBE-A8DB7E112ACBQ36004193-9D63A445-316E-4F73-95BF-8ED90E9E6920Q36359621-37CE52F6-7BBF-4D71-864F-DCA9023BC04DQ36603616-AA78DD15-CB60-46C1-B7CC-9B75842563CEQ36719083-AAEC8E83-C78B-4427-8666-F8C490F1A9D9Q37136960-927C248E-BDF5-48F8-92C5-F9986421FE00Q37334609-FD88205F-8A6B-4DDA-8C6E-70CFCC9B1E87Q37517945-BAB3C2B6-89C6-4AE6-B456-A04B90C13DF5Q37662396-1D570173-55C5-46F6-B0FA-0E9BCA73E1F0Q38256411-9C775E14-2CB5-47B5-BA75-FF6777DF4EFBQ38275143-9C042F2A-9286-4D4C-A86A-2111DB26AAD1Q38463397-D1A7708C-A765-4AE5-91B9-FEE25B5BE283Q40043361-A2098AA8-21BB-401C-BD83-014012F15A9FQ49716898-9474EFBE-C7DA-465F-B847-74410673A2C1Q52576037-8026EA93-8FA4-4EAA-8A87-069D284E163CQ52684155-D4BF4D77-D7B8-4D35-8391-7F48A5DEF211
P2860
Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Alternative RNA splicing produ ...... que transcriptional activities
@ast
Alternative RNA splicing produ ...... que transcriptional activities
@en
type
label
Alternative RNA splicing produ ...... que transcriptional activities
@ast
Alternative RNA splicing produ ...... que transcriptional activities
@en
prefLabel
Alternative RNA splicing produ ...... que transcriptional activities
@ast
Alternative RNA splicing produ ...... que transcriptional activities
@en
P2860
P356
P1476
Alternative RNA splicing produ ...... que transcriptional activities
@en
P2093
John P O'Rourke
P2860
P304
P356
10.1128/MCB.01870-07
P407
P50
P577
2008-01-14T00:00:00Z